Since adiponectin and leptin exert antagonistic effects on liver fibrogenesis and inflammation, the ratio of adiponectin to leptin might be a better marker with which to distinguish NASH from NAFLD. The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.